CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services, including medical, pharmacy, dental and behavioral health plans, medical management capabilities, Medicare Advantage and Medicare Supplement plans, PDPs and Medicaid health care management services. It serves employer groups, individuals, college students, part-time and hourly workers, health plans, health care providers, governmental units, government-sponsored plans, labor groups, and expatriates. The Health Services segment offers pharmacy benefit management solutions, including plan design and administration, formulary management, retail pharmacy network management, specialty and mail order pharmacy, clinical, disease management, medical spend management services, and other administrative services. It serves employers, insurance companies, unions, government employee groups, health plans, prescription drug plans, Medicaid managed care plans, CMS, plans offered on public health insurance, and other sponsors of health benefit plans. The Pharmacy & Consumer Wellness segment sells prescription and over-the-counter drugs, consumer health and beauty products, and personal care products. This segment also distributes prescription drugs; and provides related pharmacy consulting and other ancillary services to care facilities and other care settings. It operates online retail pharmacy websites, LTC pharmacies and on-site pharmacies, retail specialty pharmacy stores, compounding pharmacies and branches for infusion and enteral nutrition services. The company was formerly known as CVS Caremark Corporation and changed its name to CVS Health Corporation in September 2014. CVS Health Corporation was incorporated in 1996 and is headquartered in Woonsocket, Rhode Island.

CVS Health Corporation

In a report released today, Lance Wilkes from Bernstein maintained a Buy rating on CVS Health, with a price target of $106.00. Wilkes covers the He...

Bernstein Keeps Their Buy Rating on CVS Health (CVS)

In a report released today, Lisa Gill from J.P. Morgan maintained a Buy rating on CVS Health, with a price target of $118.00. Gill covers the Healt...

J.P. Morgan Remains a Buy on CVS Health (CVS)

CVS Group plc ( ($GB:CVSG) ) just unveiled an update. CVS Group plc has disclosed that Non-Executive Director Joanne Shaw purchased 1,592 ordinary ...

CVS Group Non-Executive Director Joanne Shaw Increases Shareholding

Wells Fargo analyst Stephen Baxter maintained a Buy rating on CVS Health today and set a price target of $123.00. According to TipRanks, Baxter is ...

Wells Fargo Keeps Their Buy Rating on CVS Health (CVS)

There’s a lot to be optimistic about in the Consumer Goods sector as 2 analysts just weighed in on Perdoceo Education (PRDO) and Covista (CVSA) wit...

Analysts Offer Insights on Consumer Goods Companies: Perdoceo Education (PRDO) and Covista (CVSA)

In a report released yesterday, Ben Hendrix from RBC Capital maintained a Buy rating on CVS Health, with a price target of $113.00. According to Ti...

RBC Capital Sticks to Their Buy Rating for CVS Health (CVS)

An update from CVS Group plc ( ($GB:CVSG) ) is now available. CVS Group plc disclosed that its Chief Financial Officer, Robin Alfonso, has purchase...

CVS Group CFO Increases Stake with On‑Market Share Purchase

CVS Group plc ( ($GB:CVSG) ) just unveiled an announcement. CVS Group plc has disclosed that its non-executive chairman, David Wilton, purchased 1,...

CVS Group Chairman Increases Stake With Share Purchase

CVS Health shares ($CVS) fell about 6% on Wednesday despite net income nearly tripling to $2.98 billion, or $2.31 per share, for the second quarter...

CVS Stock Drops 6% as Early 2027 Warnings Shadow Strong $2.9 Billion Profit Beat

In a report released today, from Deutsche Bank reiterated a Buy rating on CVS Group plc, with a price target of p1,700.00. Currently, the analyst c...

CVS Group plc (CVSG) Gets a Buy from Deutsche Bank

In a report released today, Kevin Caliendo from UBS maintained a Buy rating on CVS Health, with a price target of $122.00. Caliendo covers the Heal...

UBS Sticks to Its Buy Rating for CVS Health (CVS)

Berenberg Bank analyst reiterated a Buy rating on CVS Group plc today and set a price target of p2,000.00. The word on The Street in general, sugge...

CVS Group plc (CVSG) Gets a Buy from Berenberg Bank

In a report released today, Sharanya Gajapathy from Barclays maintained a Hold rating on CVS Group plc, with a price target of £13.40. In a report ...

Barclays Sticks to Their Hold Rating for CVS Group plc (CVSG)

Stocks ended the week lower as weakness in technology shares and disappointing corporate outlooks weighed on the major U.S. indexes. The Dow Jones ...

	A	B	C	D
1	Symbol	Price	Change	Volume
2	CVS	$97.16	+2.28%	9.44M
3
4
5

	A	B	C	D
1	Symbol	Price	Change	Vol
2	CVS	$97.16	+2.3%	9.44M
3
4
5
6

CVS

Get CVS Health Corporation Data in Excel

Get CVS Health Corporation Data in Excel